NEUROMETRIX, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-12-30: Form 8-K; Period of report 2015-12-29; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 1.01.
- 2015-12-01: Form 8-K; Period of report 2015-12-01; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Details 5.03.
- 2015-10-30: Form 8-K; Period of report 2015-10-30; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2015-10-22: Form 8-K; Period of report 2015-10-22; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-12-30 | 8-K | 2015-12-29 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 3.02 The shares of Preferred Stock, Warrants and Placement Agent Warrants described above have not been registered under the Securities Act of 1933, as amended. 3.03 The Company filed the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing and designating the Preferred Stock. 5.03 On December 29, 2015, the Company filed the Certificate of Designation, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference. 8.01 On December 29, 2015, the Company issued a press release announcing the Offering. | v428060_8k.htm |
| 2015-12-01 | 8-K | 2015-12-01 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 (a) On December 1, 2015, NeuroMetrix, Inc. (the “Corporation”) filed a Certificate of Amendment to its Restated Certificate of Incorporation, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference, with the Secretary of State of the State of Delaware. | v425963_8k.htm |
| 2015-10-30 | 8-K | 2015-10-30 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 (a) NeuroMetrix, Inc. (the “Corporation”) held a Special Meeting (the “Special Meeting”) on October 30, 2015 at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA 02111. | v423342_8k.htm |
| 2015-10-22 | 8-K | 2015-10-22 | 2.02 Results of Operations and Financial Condition | 2.02 On October 22, 2015, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and nine months ended September 30, 2015. | v422537_8k.htm |
| 2015-07-22 | 8-K | 2015-07-22 | 2.02 Results of Operations and Financial Condition | 2.02 On July 22, 2015, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and six months ended June 30, 2015. | v415766_8-k.htm |
| 2015-07-17 | 8-K | 2015-07-16 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On July 16, 2015, NeuroMetrix, Inc. (the “Company”) received a notice from the Listing Qualifications Department of the NASDAQ Stock Market indicating that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued inclusion on The NASDAQ Capital Market under NASDAQ Listing Rule 5550(a)(2). | v415640_8k.htm |
| 2015-06-08 | 8-K | 2015-06-08 | 8.01 Other Events | 8.01 On May 29, 2015, NeuroMetrix, Inc. (the “Company”) closed an underwritten public offering of 147,000 units (the “Offering”), with each unit consisting of one share of Series B convertible preferred stock and 99 warrants exercisable for 99 shares of common stock, at a public offering price of $100 per unit. | v412650_8-k.htm |
| 2015-05-29 | 8-K | 2015-05-26 | 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.03 The information disclosed in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03. 5.03 On May 26, 2015, NeuroMetrix, Inc. (the “Company”) filed with the Delaware Secretary of State a Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, that created the Company’s new Series B Convertible Preferred Stock, designated 147,000 shares of the Company’s preferred stock as Series B Convertible Preferred Stock and designated the preferences, rights and limitations of the Series B Convertible Preferred Stock. | v411741_8-k.htm |
| 2015-05-06 | 8-K | 2015-05-05 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 (e) At the NeuroMetrix, Inc. (the “Corporation”) Annual Meeting of Stockholders held on May 5, 2015 (the “Annual Meeting”), the stockholders of the Corporation approved the Corporation’s Seventh Amended and Restated 2004 Stock Option and Incentive Plan (the “2004 Stock Option and Incentive Plan”). 5.07 (a) The Corporation’s Annual Meeting was held on May 5, 2015 at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA 02111. | v409627_8-k.htm |
| 2015-05-01 | 8-K | 2015-04-30 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On April 30, 2015, NeuroMetrix, Inc. (the “Company”) received a deficiency letter from The NASDAQ Stock Market LLC (“NASDAQ”) indicating that, as of March 31, 2015 the Company’s reported stockholders’ equity of $1,681,643 did not meet the $2,500,000 minimum required to maintain continued listing, as set forth in NASDAQ Listing Rule 5550(b)(1), and that as of April 29, 2015 the Company does not meet the alternatives of market value of listed securities or net income from continuing operations. | v409215_8k.htm |
| 2015-04-21 | 8-K | 2015-04-21 | 2.02 Results of Operations and Financial Condition | 2.02 On April 21, 2015, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2015. | v407786_8k.htm |
| 2015-02-12 | 8-K | 2015-02-12 | 2.02 Results of Operations and Financial Condition | 2.02 On February 12, 2015, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2014. | v401370_8k.htm |